Phase 1 Open-label Study of 123I-ATT001 in Subjects With Relapsed Glioblastoma
NCT06650605
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioma Glioblastoma Multiforme
Interventions
DRUG:
123I-ATT001
Sponsor
Theragnostics Ltd